Cineverse Corp.

CNVS

CIK 0001173204 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$16M
↓-60.0% -$24Mvs FY2024 (Q4)
Operating Income
$4M
↓-53.5% -$5Mvs FY2024 (Q4)
Gross Profit
$16M
↓-60.0% -$24Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
48/100
  • Profitability
    84ROIC 21.7% (10% = solid, 20%+ = moat)
  • Liquidity
    30Current Ratio 1.11 (above 1.5 = solid)
  • Leverage
    100D/E 0.00 (under 0.5 = conservative)
  • Efficiency
    72Asset Turnover 1.14x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -60.0% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin -4.0% · trend -22.4pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project CNVS's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 56.3%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$32.59
Total enterprise IV
$581M
Diluted shares
0.02B
Terminal PV
$451M (78% of total)
Year-5 FCF
$53M
YearProjected FCFDiscounted PV
+1$22M$20M
+2$27M$22M
+3$34M$26M
+4$43M$29M
+5$53M$33M
Terminal$726M$451M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
investment in PP&E
Stock buybacks (TTM)
$0
share count reduction
Stock-based comp (TTM)
$2M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$69M
everything owned
Total liabilities
$31M
everything owed
Stockholders' equity
$39M
shareholder claim
Net debt
$-309K
Net cash position ($309K)

Recent performance · 63 quarters

Revenue↓-60.0% -$24M
$16M
Net Income↓-112.2% -$8M
$-875K
Free Cash Flow↓-519.6% -$12M
$-15M
Operating Margin↓-27.2pts
-4.0%

Drill down